Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 7-8: HPV vaccination: from seroprevalence to public health policy and everything in between
Submit an article Journal homepage
794
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Sex differences in HPV immunity among adults without cancer

Melina J. Windona Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAORCID Iconhttps://orcid.org/0000-0002-0904-2931View further author information
ORCID Icon,
Tim Waterboerb Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, GermanyView further author information
,
Alexander T. Hillela Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
Wade Chiena Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
Simon Besta Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
Charles Stewarta Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
Lee Aksta Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
Tanya Troyc Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USAView further author information
,
Noemi Benderb Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, GermanyView further author information
,
Brett Milesd Department of Otolaryngology Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
William R. Ryane Head and Neck Surgery, Department of Otolaryngology, University of California San Francisco, San Francisco, CA, USAView further author information
,
Rajarsi Mandala Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
Karen Pitmana Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
David W. Eiselea Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USAView further author information
,
Carole Fakhrya Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USA;c Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA;f Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected] [email protected]
View further author information
&
Gypsyamber D’Souzaa Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, USA;c Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected] [email protected]
View further author information
 show all
Pages 1935-1941 | Received 27 Sep 2018, Accepted 06 Jan 2019, Published online: 19 Mar 2019

References

  • Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301. doi:10.1200/JCO.2011.36.4596.
  • D’Souza G, Westra WH, Wang SJ, van Zante A, Wentz A, Kluz N, Rettig E, Ryan WR, Ha PK, Kang H, et al. Differences in the prevalence of Human Papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method. JAMA Oncol. 2017;3(2):169–177. doi:10.1001/jamaoncol.2016.3067.
  • Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(2):541-50. doi:10.1158/1055-9965.EPI-08-0347.
  • Gillison ML, Broutian T, Pickard RKL, Tong Z-Y, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012;307(7):693–703. doi:10.1001/jama.2012.101.
  • Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong Z-Y, Xiao W, Kahle L, Gillison ML. NHANES 2009–2012 findings: association of sexual behaviors with higher prevalence of oral oncogenic human papillomavirus infections in U.S. men. Cancer Res. 2015;75(12):2468–77. doi:10.1158/0008-5472.CAN-14-2843.
  • Tam S, Fu S, Xu L, Krause KJ, Lairson DR, Miao H, Sturgis EM, Dahlstrom KR. The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018;82:91–99. doi:10.1016/j.oraloncology.2018.04.005.
  • D'Souza G, McNeel TS, Fakhry C, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017:28;3065–3069.
  • D’Souza G, Wentz A, Kluz N, Zhang Y, Sugar E, Youngfellow RM, Guo Y, Xiao W, Gillison ML. Sex differences in risk factors and natural history of oral human papillomavirus infection. J Infect Dis. 2016;213(12):1893–96. doi:10.1093/infdis/jiw063.
  • D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199(9):1263–69. doi:10.1086/597755.
  • Fink AL, Klein SL. the evolution of greater humoral immunity in females than males : implications for vaccine efficacy. Curr Opin Psychol. 2018;5:16–20. doi: 10.1016/j.cophys.2018.03.010. 6:16–20.
  • Svare EI, Kjaer SK, Nonnenmacher B, Worm A-M, Moi H, Christensen RB, van Den Brule AJC, Walboomers JMM, Meijer CJLM, Hubbert NL, et al. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. J Infect Dis. 1997;176:876–883. doi:10.1086/jid.1997.176.issue-4.
  • Strickler HD, Kirk GD, Figueroa JP, Ward E, Braithwaite AR, Escoffery C, Drummond J, Goebel B, Waters D, McClimens R, et al. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. Int J Cancer. 1999;80:339–44.
  • Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER, Reeves WC. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 2002;186(10):1396–402. doi:10.1086/344354.
  • Thompson DL, Douglas JM Jr, Foster M, Hagensee ME, Diguiseppi C, Barón AE, Cameron JE, Spencer TC, Zenilman J, Malotte CK, et al. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the united states. J Infect Dis. 2004;190(9):1563–74. doi:10.1086/423817.
  • Kreimer AR, Alberg AJ, Viscidi R, Gillison ML. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, −18, and −33 seroprevalence. Sex Transm Dis. 2004;31:247–56.
  • Furniss CS, McClean MD, Smith JF, Bryan J, Nelson HH, Peters ES, Posner MR, Clark JR, Eisen EA, Kelsey KT. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer. 2007;120(11):2386–92. doi:10.1002/ijc.22633.
  • National Health and Nutrition Examination Survey Data (NHANES). NHANES 2011–2012. Questionnaire Instruments. Hyattsville (MD); 2012 [accessed 2018 June 27]. cdc.gov/nchs/nhanes/continuousnhanes/questionnaires.aspx?BeginYear=2011
  • Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin Chem. 2005;51(10):1845–53. doi:10.1373/clinchem.2005.052381.
  • Clifford GM, Shin HR, Oh JK, Waterboer T, Ju Y-H, Vaccarella S, Quint W, Pawlita M, Franceschi S. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1874–79. doi:10.1158/1055-9965.EPI-07-0349.
  • Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, Page R, Lind MJ, Peake MD, Møller H. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013;31(21):2708–15. doi:10.1200/JCO.2013.49.0219.
  • Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3235–42. doi:10.1200/JCO.2015.61.6995.
  • D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56. doi:10.1056/NEJMoa065497.
  • Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H. HPV DNA, E6/E7 mRNA, and p16INK4adetection in head and neck cancers: A systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319–31. doi:10.1016/S1470-2045(14)70471-1.
  • Guo T, Eisele DW, Fakhry C. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer. 2016;122(15):2313–23. doi:10.1002/cncr.29992.
  • Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst. 2003;95:1062–71.
  • Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol. 1999;37:1030–34.
  • Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis. 2000;181(6):1911–19. doi:10.1086/315498.
  • Heiligenberg M, Michael KM, Kramer MA, Pawlita M, Prins M, Coutinho RA, Dukers-Muijrers NHTM, Waterboer T. Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: A population-based study in Amsterdam. Sex Transm Dis. 2010;37(11):672–80. doi:10.1097/OLQ.0b013e3181e71069.
  • Desai S, Chapman R, Jit M, Nichols T, Borrow R, Wilding M, Linford C, Lowndes CM, Nardone A, Pebody R, et al. Prevalence of human papillomavirus antibodies in males and females in England. Sex Transm Dis. 2011;38(7):622–29. doi:10.1097/OLQ.0b013e31820bc880.
  • Newall AT, Brotherton JML, Quinn HE, McIntyre PB, Backhouse J, Gilbert L, Esser MT, Erick J, Bryan J, Formica N, et al. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clin Infect Dis. 2008;46(11):1647–55. doi:10.1086/587895.
  • Beachler DC, Sugar EA, Margolick JB, Weber KM, Strickler HD, Wiley DJ, Cranston RD, Burk RD, Minkoff H, Reddy S, et al. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol. 2015;181(1):40–53. doi:10.1093/aje/kwu247.
  • Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N. Natural acquired immunity against subsequent genital human papillomavirus infection: A systematic review and meta-analysis. J Infect Dis. 2016;213(9):1444–54. doi:10.1093/infdis/jiv753.
  • Klein SL. The evolution of greater humoral immunity in females than males: implications for vaccine efficacy. Current Opinion in Physiology. 2018;6:16–20. doi:10.1016/j.cophys.2018.03.010.
  • Beachler D, Pinto L, Kemp TJ, Nyitray, AG, Hildesheim, A, Viscidi, R, Giuliano, AR. et al. An examination of HPV16 natural immunity in men who have sex with men (MSM) in the HPV in men (HIM) study. Cancer Epidemiol Biomarkers Prev. 2018; cebp.0853.2017.
  • Koutsky LA, Ault KA, Wheeler CM, Brown, DR, Barr, E, Alvarez, FB, Jansen, KU. et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2018;347(21).
  • Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong Z-Y, Xiao W, Kahle L, Gillison ML. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol. 2018;36(3):262–67. doi:10.1200/JCO.2017.75.0141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.